APA (7th ed.) Citation

Guijarro, L. G., Sanmartin-Salinas, P., Pérez-Cuevas, E., Toledo-Lobo, M. V., Monserrat, J., Zoullas, S., . . . Ortega, M. A. (2021). Actinomycin D Arrests Cell Cycle of Hepatocellular Carcinoma Cell Lines and Induces p53-Dependent Cell Death: A Study of the Molecular Mechanism Involved in the Protective Effect of IRS-4. Pharmaceuticals (14248247), 14(9), 845. https://doi.org/10.3390/ph14090845

Chicago Style (17th ed.) Citation

Guijarro, Luis G., et al. "Actinomycin D Arrests Cell Cycle of Hepatocellular Carcinoma Cell Lines and Induces P53-Dependent Cell Death: A Study of the Molecular Mechanism Involved in the Protective Effect of IRS-4." Pharmaceuticals (14248247) 14, no. 9 (2021): 845. https://doi.org/10.3390/ph14090845.

MLA (9th ed.) Citation

Guijarro, Luis G., et al. "Actinomycin D Arrests Cell Cycle of Hepatocellular Carcinoma Cell Lines and Induces P53-Dependent Cell Death: A Study of the Molecular Mechanism Involved in the Protective Effect of IRS-4." Pharmaceuticals (14248247), vol. 14, no. 9, 2021, p. 845, https://doi.org/10.3390/ph14090845.